Skip to main content

Cholesterol clinical trials at UC Irvine

2 in progress, 0 open to eligible people

Showing trials for
  • Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

    Sorry, in progress, not accepting new patients

    Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants with established cardiovascular disease (CVD).

    Irvine 5359777, California 5332921 and other locations

  • VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

    Sorry, in progress, not accepting new patients

    VictORION-INCLUSION (V-INCLUSION) seeks to evaluate the effectiveness of inclisiran as an innovative therapy with the potential to help bridge care gaps in historically understudied and undertreated populations by leveraging electronic health records (EHR) in multiple US Healthcare Systems (HCS) to systematically identify those at high risk for and already diagnosed with ASCVD for more expeditious achievement of LDL-C targets.

    Orange 5379513, California 5332921 and other locations

Last updated: